﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-09-18T10:39:58-04:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>760488684</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>DONHAM &amp; WILLIAMS PC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>2404 S GRAND BLVD STE 120</AddressLine1Txt>
        <CityNm>PEARLAND</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>77581</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>844672869</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>STAAR OVARIAN CANCER</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>STAA</BusinessNameControlTxt>
      <PhoneNum>2819239051</PhoneNum>
      <USAddress>
        <AddressLine1Txt>230 E OHIO STREET SUITE 410 1185</AddressLine1Txt>
        <CityNm>CHICAGO</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60611</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>NICOLE ANDREWS</PersonNm>
      <PersonTitleTxt>CHAIR</PersonTitleTxt>
      <PhoneNum>2819239051</PhoneNum>
      <SignatureDt>2024-09-03</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>false</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>ANDREA P WILLIAMS</PreparerPersonNm>
      <PTIN>P00448841</PTIN>
      <PhoneNum>2819972033</PhoneNum>
      <PreparationDt>2024-09-18</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-08-08 14:25:15Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="5">
    <IRS990 documentId="RetDoc2" referenceDocumentId="RetDoc4">
      <PrincipalOfficerNm>NICOLE ANDREWS</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>2301 GOSTICK</AddressLine1Txt>
        <CityNm>HOUSTON</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>77008</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>399588</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.STAAROC.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationOtherInd>X</TypeOfOrganizationOtherInd>
      <FormationYr>2020</FormationYr>
      <LegalDomicileStateCd>IL</LegalDomicileStateCd>
      <ActivityOrMissionDesc>STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPLE OF OVARIAN CANCER IN THE UNITED STATES. WE DRIVE AWARENESS OF THE SYMPTOBS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE STRENGTHEN OUR CONNECTIONS WITH RESEARCHERS TO UNDERSTAND RESEARCH NEEDS, FUNDING NEEDS, AND HISTORICALLY RAISED ENOUGH FUNDS THROUGH DONATIONS TO GIVE THREE RESEARCH GRANTS FOR LGSOC. ONE OF THE FUNDED STUDIES WAS FUNDED WITH MONEY DONATED IN 2021.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>9</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>9</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>15</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>310800</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>327751</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>71500</CYProgramServiceRevenueAmt>
      <CYInvestmentIncomeAmt>337</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>310800</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>399588</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>476000</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>153000</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>37766</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>124067</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>513766</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>277067</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-202966</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>122521</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>164305</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>448000</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>137500</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>299152</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>26805</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>148848</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPE OF OVARIAN CANCER IN THE UNTED STATES. THROUGHOUT THE YEAR, WE DROVE AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE MAKE CONNECTIONS WITH RESEARCHERS AND ULTIMATELY HAVE MADE THREE GRANTS, SOOME WITH FUNDS RAISED IN 2021.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>44670</ExpenseAmt>
      <Desc>CONTINUING SUPPORTING AND EXPANDING AN AWARENESS CAMPAIGN OF LGSOC.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>153000</ExpenseAmt>
        <GrantAmt>153000</GrantAmt>
        <Desc>AWARDED RESEARCH GRANTS FOR LGSOC</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>79397</ExpenseAmt>
        <RevenueAmt>71500</RevenueAmt>
        <Desc>CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT FOCUSED DRUG DEVELOPMENT MEETING AS DIRECTED BY THE US FDA FOR PATIENTS TO PRESENT THEIR PERSPECTIVES ON LIVING WITH THEIR RARE DISEASE AND THEIR DAILY LIFE WITH THE CURRENT TREATMENTS. PROVIDE A PLATFORM FOR PATIENTS TO SHARE THEIR THOUGHTS ON DRUG DEVELOPMENT AND SIDE EFFECTS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <Desc>ANY OTHER MARKETING RESEARCH SUPPORT SERVICES THAT BENEFITS AWARENESS OF LGSC SUB-TYPE.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalProgramServiceExpensesAmt>277067</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc5">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd>false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd>false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd>false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd>false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd>false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc3">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc3">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>0</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>false</BackupWthldComplianceInd>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>9</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>9</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <BooksInCareOfDetail>
        <PersonNm>CHRISTINA CAMPBELL</PersonNm>
        <PhoneNum>2819239051</PhoneNum>
        <USAddress>
          <AddressLine1Txt>4618 SPEARS ROAD</AddressLine1Txt>
          <CityNm>MANVEL</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>77578</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELLIE HABIB</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MADALYN KENNEY</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BAILEY WOLFE</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NICOLE ANDREWS</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHRISTINA CAMPBELL</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MORGAN GAYNOR</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KARI NEUMEYER</PersonNm>
        <TitleTxt>V-CHAIR MARK</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>EMMA SCHLAMM</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALYSSA TOOMES</PersonNm>
        <TitleTxt>V-CHAIR FUND</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>327751</AllOtherContributionsAmt>
      <TotalContributionsAmt>327751</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>ELPFDD MEETING INCOME</Desc>
        <TotalRevenueColumnAmt>71500</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>71500</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>71500</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>337</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>337</RelatedOrExemptFuncIncomeAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>399588</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>71837</RelatedOrExemptFuncIncomeAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>153000</TotalAmt>
        <ProgramServicesAmt>153000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>2107</TotalAmt>
        <ProgramServicesAmt>2107</ProgramServicesAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>441</TotalAmt>
        <ProgramServicesAmt>441</ProgramServicesAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>78965</TotalAmt>
        <ProgramServicesAmt>78965</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>598</TotalAmt>
        <ProgramServicesAmt>598</ProgramServicesAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>2580</TotalAmt>
        <ProgramServicesAmt>2580</ProgramServicesAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>2052</TotalAmt>
        <ProgramServicesAmt>2052</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <OtherExpensesGrp>
        <Desc>AWARENESS MATERIALS</Desc>
        <TotalAmt>37324</TotalAmt>
        <ProgramServicesAmt>37324</ProgramServicesAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>277067</TotalAmt>
        <ProgramServicesAmt>277067</ProgramServicesAmt>
        <ManagementAndGeneralAmt>0</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>164305</BOYAmt>
        <EOYAmt>448000</EOYAmt>
      </CashNonInterestBearingGrp>
      <TotalAssetsGrp>
        <BOYAmt>164305</BOYAmt>
        <EOYAmt>448000</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>137500</BOYAmt>
        <EOYAmt>299152</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>137500</BOYAmt>
        <EOYAmt>299152</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>26805</BOYAmt>
        <EOYAmt>148848</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>26805</BOYAmt>
        <EOYAmt>148848</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>164305</BOYAmt>
        <EOYAmt>448000</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>122521</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>-478</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc5">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus3YearsAmt>71361</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>168011</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>310800</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>327751</CurrentTaxYearAmt>
        <TotalAmt>877923</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearAmt>71837</CurrentTaxYearAmt>
        <TotalAmt>71837</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus3YearsAmt>71361</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>168011</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>310800</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>399588</CurrentTaxYearAmt>
        <TotalAmt>949760</TotalAmt>
      </Total509Grp>
      <PublicSupportTotal509Amt>949760</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus3YearsAmt>242</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>326</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>568</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>1136</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus3YearsAmt>242</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>326</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>568</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>1136</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus3YearsAmt>71603</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>168337</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>311368</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>399588</CurrentTaxYearAmt>
        <TotalAmt>950896</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.99880</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.99790</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleI documentId="RetDoc3">
      <GrantRecordsMaintainedInd>false</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE UNIVERSITY OF TEXAS MD ANDERSON</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>CANCER CENTER</BusinessNameLine2Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 301439</AddressLine1Txt>
          <AddressLine2Txt>UNIT 1362</AddressLine2Txt>
          <CityNm>HOUSTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>772301429</ZIPCd>
        </USAddress>
        <RecipientEIN>746001118</RecipientEIN>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>53000</CashGrantAmt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>NONE</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>RESEARCH ON LOW</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF OKLAHOMA HEALTH</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>SYSTEMS</BusinessNameLine2Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>975 NE 10TH ST BRC 1217A</AddressLine1Txt>
          <CityNm>OKLAHOMA CITY</CityNm>
          <StateAbbreviationCd>OK</StateAbbreviationCd>
          <ZIPCd>73104</ZIPCd>
        </USAddress>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>100000</CashGrantAmt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </RecipientTable>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PAGE 1, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>STAAR OC ACCEPTS GRANT APPLICATIONS FROM LOW-GRADE SEROUS OVARIAN CANCER RESEARCHRS IN THE US IF IT MEETS OUR CRITERIA FOR FUTHERING THE RESEARCH LITERATURE IN TREATMENT OPTIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc4">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPE OF OVARIAN CANCER IN THE UNTED STATES. THROUGHOUT THE YEAR, WE DROVE AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE MAKE CONNECTIONS WITH RESEARCHERS AND ULTIMATELY HAVE MADE THREE GRANTS, SOOME WITH FUNDS RAISED IN 2021.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4D</FormAndLineReferenceDesc>
        <ExplanationTxt>ANY OTHER MARKETING RESEARCH SUPPORT SERVICES THAT BENEFITS AWARENESS OF LGSC SUB-TYPE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>MORE THAN ONE OFFICER REVIEWED THE FORM PRIOR TO SUBMISSION</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>OUR POLICY IS MAILED TO THE BOARD ANNUALLY AND EACH MEMBER SIGNS THAT THEY HAVE RECEIVED IT IN ADDITION TO FILING OUT A CONFLICT OF INTEREST FORM.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>WE HAVE NOT MADE THOSE DOCUMENTS PUBLIC</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>ELPFDD MEETING INCOME WRITING SUPPORT 8,650 0 0 VIDEO PRODUCTION 38,215 0 0 FDA MEETING SUPPORT SERVI 32,100 0 0 TOTAL 78,965 0 0</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9</FormAndLineReferenceDesc>
        <ExplanationTxt>PY ADJ -478</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>